Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. It works by suppressing the immune system to help maintain transplant success.

Certican is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It is often prescribed to patients who have undergone organ transplantation to help their bodies accept the new organ. The medication works by suppressing the immune system's response to the transplanted organ, reducing the risk of rejection. Certican may also be used in other medical contexts where immune suppression is necessary, as determined by a healthcare provider.

Common effects of Certican may include headaches, nausea, and fatigue. Some users might experience swelling in the limbs or mild digestive issues. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Certican should be handled with care, especially by individuals with pre-existing conditions like liver or kidney problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be required to ensure the medication's safety and effectiveness.

Certican may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. This includes some antibiotics, antifungals, and HIV medications. Alcohol consumption should be discussed with a healthcare provider, as it may affect the medication's efficacy or increase the risk of side effects.